The American Journal of Hematology awarded Yiwen Liu, MS and collaborators with its 2021 Young Investigator Award. The honor is given annually to the first author(s) of one select publication.
Ms. Liu and co-authors Matthew L. Meizlish, George Goshua, and Rebecca Fine published one of the first studies on the use of intermediate anticoagulation and aspirin on the survival outcomes of in-hospital COVID patients. The findings reveal potential factors in the complicated decision making process of treating intermediate to severe COVID patients in the hospital setting in the early days of the pandemic.
“Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis” first appeared in the American Journal of Hematology’s April 2021 issue.
“I am glad that my statistical expertise can help with decision-making in frontline COVID treatment therapies and this successful collaboration between the clinical team at Yale and the Data Science team at Dana-Farber,” says Liu.